Not available
Quote | Adamas Pharmaceuticals Inc. (NASDAQ:ADMS)
Last: | $8.22 |
---|---|
Change Percent: | 0.74% |
Open: | $8.24 |
Close: | $8.22 |
High: | $8.25 |
Low: | $8.18 |
Volume: | 3,151,400 |
Last Trade Date Time: | 11/23/2021 04:55:24 pm |
News | Adamas Pharmaceuticals Inc. (NASDAQ:ADMS)
Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) are up ~10% in after-hours trading after the company boosted its full-year earnings guidance and beat Q3 earnings estimates. Operating earnings for 2021 are now expected to be $90M-$95M, up from prior guidance of $70M-$90M. Net produc...
NEW YORK, NY / ACCESSWIRE / November 1, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) concerning potential violations of the federal securities laws and/or breaches of fiducia...
Message Board Posts | Adamas Pharmaceuticals Inc. (NASDAQ:ADMS)
Subject | By | Source | When |
---|---|---|---|
ADMS Chart | conix | investorshub | 10/11/2021 9:08:25 PM |
znewcar1: ADMS 75% v32,2M c8.07 f45,5M fw@28M@$5 | znewcar1 | investorshangout | 10/11/2021 8:03:45 PM |
$6.10 nice | wesley_ | investorshub | 04/28/2021 1:50:11 PM |
Perhaps the "analysts" and their friends have loaded | slow_feet | investorshub | 02/04/2021 4:30:15 PM |
i got caught up in those Halts. Chased | mm107 | investorshub | 02/01/2021 9:47:44 PM |
Adamas Pharmaceuticals Inc. Company Name:
ADMS Stock Symbol:
NASDAQ Market:
Adamas Pharmaceuticals Inc. Website:
Supernus Pharmaceuticals (NASDAQ: SUPN) recently announced that it's acquiring Adamas Pharmaceuticals (NASDAQ: ADMS) . In this Motley Fool Live video recorded on Oct. 13 , Motley Fool contributors Keith Speights and Brian Orelli discuss why Supernus' planned acq...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Adamas Pharmaceuticals, Inc. Announces Definitive Agreement to be Acquired by Supernus Pharmaceuticals, Inc” Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) surged ove...
Supernus Pharmaceuticals Inc ( NASDAQ: SUPN ) recently announced that it had entered a definitive contract to acquire Adamas Pharmaceuticals ( NASDAQ: ADMS ). Supernus is to purchase this company a tender offer that was worth about $8.10 per share. The aggregate was roug...